Rekombinanter VEGF (Bevacizumab Biosimilar) Antikörper
Reaktivität: Human
FACS, ELISA, BR, IP, WB
Wirt: Maus
Chimeric
unconjugated
Recombinant Antibody
-
- Target Alle VEGF (Bevacizumab Biosimilar) Produkte
- VEGF (Bevacizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Chimeric
-
Konjugat
- Dieser VEGF (Bevacizumab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)
- Produktmerkmale
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Aufreinigung
- Purified antibody.
- Immunogen
- Recombinant human VEGF.
- Isotyp
- IgG2a kappa
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- VEGF (Bevacizumab Biosimilar)
- Abstract
- VEGF (Bevacizumab Biosimilar) Produkte
- Synonyme
- MVCD1 antikoerper, VEGF antikoerper, VPF antikoerper, vascular endothelial growth factor A antikoerper, VEGFA antikoerper
- Hintergrund
- Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
- UniProt
- P15692
-
Sie sind hier:
